Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort
Author:
Affiliation:
1. Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
2. Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Germany
Funder
Office of the Assistant Secretary of Defense for Health Affairs
Breast Cancer Research Program
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
http://academic.oup.com/jnci/article-pdf/111/4/365/28279433/djy115.pdf
Reference30 articles.
1. Selective estrogen-receptor modulators—mechanisms of action and application to clinical practice;Riggs;N Engl J Med,2003
2. Molecular determinants for the tissue specificity of SERMs;Shang;Science,2002
3. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study;Fisher;J Natl Cancer Inst,1998
4. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator;DuSell;Mol Endocrinol,2008
5. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology;Nelson;Science,2013
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Association between remnant cholesterol and the risk of 4 site-specific cancers: evidence from a cross-sectional and Mendelian randomization study;Lipids in Health and Disease;2024-08-20
2. Neutrophils exposed to a cholesterol metabolite secrete extracellular vesicles that promote epithelial-mesenchymal transition and stemness in breast cancer cells;2024-08-02
3. Remnant cholesterol is an effective biomarker for predicting survival in patients with breast cancer;Nutrition Journal;2024-04-22
4. Associations between lifestyle, health, and clinical characteristics and circulating oxysterols and cholesterol precursors in women diagnosed with breast cancer: a cross-sectional study;Scientific Reports;2024-02-29
5. Chronic disease outcome metadata from German observational studies – public availability and FAIR principles;Scientific Data;2023-12-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3